XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities    
Net income $ 322,166 $ 246,478
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 200,807 111,067
Amortization of deferred financing costs and debt discount 9,773 6,293
Straight-line rent revenue and other (161,163) (91,616)
Share / (Unit)-based compensation expense 34,600 22,119
Loss (gain) from sale of real estate and other 2,703 (62)
Impairment charges 19,006  
Straight-line rent and other write-off 27,098 7,232
Unutilized financing costs 611 4,873
Pre-acquisition rent collected - Circle Transaction (35,020)  
Other adjustments 27,187 11,643
Changes in:    
Interest and rent receivables (6,189) 528
Other assets 12,117 4,409
Accounts payable and accrued expenses (11,478) 4,413
Net cash provided by operating activities 442,218 327,377
Investing activities    
Cash paid for acquisitions and other related investments (3,524,910) (3,703,092)
Net proceeds from sale of real estate 93,042 4,859
Principal received on loans receivable 738,036 920
Investment in loans receivable (65,708) (34,149)
Construction in progress and other (42,227) (55,168)
Return of equity investment 63,122  
Capital additions and other investments, net (8,362) (213,096)
Net cash used for investing activities (2,747,007) (3,999,726)
Financing activities    
Proceeds from term debt 915,950 1,732,740
Revolving credit facilities, net 225,000 417,089
Dividends / Distribution paid (423,005) (291,675)
Lease deposits and other obligations to tenants 7,584 (8,349)
Proceeds from sale of common shares, net of offering costs 294,374 1,507,363
Payment of deferred financing costs and other financing activities (2,143) (24,187)
Net cash provided by financing activities 1,017,760 3,332,981
Decrease in cash, cash equivalents, and restricted cash for period (1,287,029) (339,368)
Effect of exchange rate changes 9,116 (16,645)
Cash, cash equivalents, and restricted cash at beginning of period 1,467,991 822,425
Cash, cash equivalents, and restricted cash at end of period 190,078 466,412
Interest paid 231,257 158,259
Supplemental schedule of non-cash financing activities:    
Dividend / Distributions declared, unpaid 144,954 120,023
Cash, cash equivalents, and restricted cash are comprised of the following:    
Cash and cash equivalents at beginning of period 1,462,286 820,868
Restricted cash, included in Other assets at beginning of period $ 5,705 $ 1,557
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of period $ 1,467,991 $ 822,425
Cash and cash equivalents at end of period 183,794 461,622
Restricted cash, included in Other assets at end of period $ 6,284 $ 4,790
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of period $ 190,078 $ 466,412
MPT Operating Partnership, L.P. [Member]    
Operating activities    
Net income 322,166 246,478
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 200,807 111,067
Amortization of deferred financing costs and debt discount 9,773 6,293
Straight-line rent revenue and other (161,163) (91,616)
Share / (Unit)-based compensation expense 34,600 22,119
Loss (gain) from sale of real estate and other 2,703 (62)
Impairment charges 19,006  
Straight-line rent and other write-off 27,098 7,232
Unutilized financing costs 611 4,873
Pre-acquisition rent collected - Circle Transaction (35,020)  
Other adjustments 27,187 11,643
Changes in:    
Interest and rent receivables (6,189) 528
Other assets 12,117 4,409
Accounts payable and accrued expenses (11,478) 4,413
Net cash provided by operating activities 442,218 327,377
Investing activities    
Cash paid for acquisitions and other related investments (3,524,910) (3,703,092)
Net proceeds from sale of real estate 93,042 4,859
Principal received on loans receivable 738,036 920
Investment in loans receivable (65,708) (34,149)
Construction in progress and other (42,227) (55,168)
Return of equity investment 63,122  
Capital additions and other investments, net (8,362) (213,096)
Net cash used for investing activities (2,747,007) (3,999,726)
Financing activities    
Proceeds from term debt 915,950 1,732,740
Revolving credit facilities, net 225,000 417,089
Dividends / Distribution paid (423,005) (291,675)
Lease deposits and other obligations to tenants 7,584 (8,349)
Proceeds from sale of units, net of offering costs 294,374 1,507,363
Payment of deferred financing costs and other financing activities (2,143) (24,187)
Net cash provided by financing activities 1,017,760 3,332,981
Decrease in cash, cash equivalents, and restricted cash for period (1,287,029) (339,368)
Effect of exchange rate changes 9,116 (16,645)
Cash, cash equivalents, and restricted cash at beginning of period 1,467,991 822,425
Cash, cash equivalents, and restricted cash at end of period 190,078 466,412
Interest paid 231,257 158,259
Supplemental schedule of non-cash financing activities:    
Dividend / Distributions declared, unpaid 144,954 120,023
Cash, cash equivalents, and restricted cash are comprised of the following:    
Cash and cash equivalents at beginning of period 1,462,286 820,868
Restricted cash, included in Other assets at beginning of period $ 5,705 $ 1,557
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of period $ 1,467,991 $ 822,425
Cash and cash equivalents at end of period 183,794 461,622
Restricted cash, included in Other assets at end of period $ 6,284 $ 4,790
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of period $ 190,078 $ 466,412